ENTITY

United Therapeutics (UTHR US)

28
Analysis
Health CareUnited States
United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease. The Company's lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.
more
Refresh
Company Presentation01 May 2024 21:00
Company Presentation21 Feb 2024 22:00
Company Presentation09 Aug 2020 23:00
Company Presentation20 Jan 2021 05:30
Company Presentation01 Nov 2023 21:00
x